Document Detail


In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent.
MedLine Citation:
PMID:  15757605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Between April 2002 and May 2004, 174 consecutive patients who underwent percutaneous coronary intervention of bifurcational lesions with sirolimus-eluting stents were identified. Two strategies were used: stenting only 1 branch (group 1S, n = 57) or stenting both branches (group 2S, n = 117). The incidence of major adverse cardiac events was evaluated in the hospital and at 9-month follow-up. There were no statistically significant differences between the 2 groups with regard to the incidence of target lesion revascularization (5.4% vs 8.9%, p = 0.76), target vessel revascularization (5.4% vs 11.1%, p = 0.51), and cumulative major adverse cardiac events (18.9% vs 23.3%, p = 0.76) at 9 months.
Authors:
Lei Ge; Eleutheria Tsagalou; Ioannis Iakovou; Giuseppe M Sangiorgi; Nicola Corvaja; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Iassen Michev; Antonio Colombo
Related Documents :
10636365 - Outcomes at 1 year and economic implications of platelet glycoprotein iib/iiia blockade...
14662245 - A randomized trial comparing primary infarct artery stenting with or without abciximab ...
20603505 - Lesion characteristics and coronary stent selection with computed tomographic coronary ...
14715195 - Severe ostial saphenous vein graft disease leading to acute coronary syndromes followin...
3121335 - Residual coronary stenosis after thrombolysis with rt-pa or streptokinase: acute result...
21289945 - The role of homocysteine as a predictor for coronary heart disease.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-10     Completed Date:  2005-04-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  757-60     Citation Subset:  AIM; IM    
Affiliation:
EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angina, Unstable / mortality,  therapy*
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Coronary Angiography
Coronary Artery Disease / mortality,  therapy*
Coronary Restenosis / mortality
Death, Sudden, Cardiac / epidemiology
Female
Follow-Up Studies
Hospital Mortality*
Humans
Male
Middle Aged
Myocardial Infarction / mortality,  therapy
Outcome and Process Assessment (Health Care)
Risk Factors
Sirolimus / adverse effects*
Stents*
Chemical
Reg. No./Substance:
53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risks of noncardiac surgery after coronary stenting.
Next Document:  Quality of life in octagenarians after coronary artery bypass grafting.